| abstract |
A process for inhibiting vascular proliferation introduces a composition into the eye inducing posterior vitreous detachment. The composition includes at least two compounds selected from the group consisting of plasmin, plasminogen, urokinase, streptokinase, tissue plasminogen activator, chondroitinase, pro-urokinase, retavase, metaloproteinase, and thermolysin in amounts sufficient to induce substantially complete or partial posterior vitreous detachment from the retina without causing inflammation of the retina and to dissolve blood clots in the vitreous. |